The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wildbaum, G.
Right arrow Articles by Karin, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wildbaum, G.
Right arrow Articles by Karin, N.
The Journal of Immunology, 1998, 161: 6368-6374.
Copyright © 1998 by The American Association of Immunologists

Neutralizing Antibodies to IFN-{gamma}-Inducing Factor Prevent Experimental Autoimmune Encephalomyelitis1

Gizi Wildbaum*, Sawsan Youssef*, Nir Grabie* and Nathan Karin2,*,{dagger}

* Department of Immunology and {dagger} Rappaport Family Institute for Research in the Medical Sciences and Bruce Rappaport Faculty of Medicine, Haifa, Israel

Specific oligonucleotide primers were used to identify and isolate IFN-{gamma}-inducing factor (IGIF) from the brain of rats with developing experimental autoimmune encephalomyelitis (EAE), a T cell-mediated autoimmune disease of the central nervous system that serves as a model for multiple sclerosis. IGIF was highly transcribed in the brain at the onset and during the course of active EAE. PCR products encoding rat IGIF were used to generate the recombinant protein that was used to induce anti-IGIF neutralizing Abs. These Abs significantly reduced the production of IFN-{gamma} by primed T cells proliferating in response to their target myelin basic protein epitope and by Con A-activated T cells from naive donors. When administered to rats during the development of either active or transferred EAE, these Abs significantly blocked the development of disease. Splenic T cells from protected rats were cultured with the encephalitogenic myelin basic protein epitope and evaluated for production of IL-4 and IFN-{gamma}. These cells, which proliferated, exhibited a profound increase in IL-4 production that was accompanied by a significant decrease in IFN-{gamma} and TNF-{alpha} production. Thus, we suggest that perturbation of the Th1/Th2 balance toward Th2 cells is the mechanism underlying EAE blockade by anti-IGIF immunotherapy.




This article has been cited by other articles:


Home page
Int ImmunolHome page
D. Neumann, T. Tschernig, D. Popa, A. Schmiedl, G. P. de Lema, K. Resch, and M. U. Martin
Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms
Int. Immunol., December 1, 2006; 18(12): 1779 - 1787.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Christensen, C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen
CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System
J. Immunol., April 1, 2006; 176(7): 4235 - 4243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. A Dinarello
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 447S - 455S.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Mazodier, V. Marin, D. Novick, C. Farnarier, S. Robitail, N. Schleinitz, V. Veit, P. Paul, M. Rubinstein, C. A. Dinarello, et al.
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Blood, November 15, 2005; 106(10): 3483 - 3489.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Cheung, N.-J. Chen, Z. Cao, N. Ono, P. S. Ohashi, and W.-C. Yeh
Accessory Protein-Like Is Essential for IL-18-Mediated Signaling
J. Immunol., May 1, 2005; 174(9): 5351 - 5357.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Schif-Zuck, J. Westermann, N. Netzer, Y. Zohar, M. Meiron, G. Wildbaum, and N. Karin
Targeted Overexpression of IL-18 Binding Protein at the Central Nervous System Overrides Flexibility in Functional Polarization of Antigen-Specific Th2 Cells
J. Immunol., April 1, 2005; 174(7): 4307 - 4315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Goldberg, Y. Zohar, G. Wildbaum, Y. Geron, G. Maor, and N. Karin
Suppression of Ongoing Experimental Autoimmune Encephalomyelitis by Neutralizing the Function of the p28 Subunit of IL-27
J. Immunol., November 15, 2004; 173(10): 6465 - 6471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Bossu, D. Neumann, E. Del Giudice, A. Ciaramella, I. Gloaguen, G. Fantuzzi, C. A. Dinarello, E. Di Carlo, P. Musiani, P. L. Meroni, et al.
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease
PNAS, November 25, 2003; 100(24): 14181 - 14186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami
Role of IL-12 Receptor {beta}1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis
J. Immunol., November 1, 2003; 171(9): 4485 - 4492.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wu, P. Sakorafas, R. Miller, D. McCarthy, S. Scesney, R. Dixon, and T. Ghayur
IL-18 Receptor {beta}-Induced Changes in the Presentation of IL-18 Binding Sites Affect Ligand Binding and Signal Transduction
J. Immunol., June 1, 2003; 170(11): 5571 - 5577.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ito, A. Matejuk, C. Hopke, H. Drought, J. Dwyer, A. Zamora, S. Subramanian, A. A. Vandenbark, and H. Offner
Transfer of Severe Experimental Autoimmune Encephalomyelitis by IL-12- and IL-18-Potentiated T Cells Is Estrogen Sensitive
J. Immunol., May 1, 2003; 170(9): 4802 - 4809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami
Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-{beta}2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System
J. Immunol., February 15, 2003; 170(4): 2153 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. A. Gracie, S. E. Robertson, and I. B. McInnes
Interleukin-18
J. Leukoc. Biol., February 1, 2003; 73(2): 213 - 224.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Sewell, Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization
Int. Immunol., January 1, 2003; 15(1): 59 - 69.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Abraham, S. Shapiro, N. Lahat, and A. Miller
The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells
Int. Immunol., December 1, 2002; 14(12): 1449 - 1457.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Hedtjarn, A.-L. Leverin, K. Eriksson, K. Blomgren, C. Mallard, and H. Hagberg
Interleukin-18 Involvement in Hypoxic-Ischemic Brain Injury
J. Neurosci., July 15, 2002; 22(14): 5910 - 5919.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Wildbaum, N. Netzer, and N. Karin
Plasmid DNA Encoding IFN-{gamma}-Inducible Protein 10 Redirects Antigen-Specific T Cell Polarization and Suppresses Experimental Autoimmune Encephalomyelitis
J. Immunol., June 1, 2002; 168(11): 5885 - 5892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wang, C. Feliciani, B. G. Howell, I. Freed, Q. Cai, H. Watanabe, and D. N. Sauder
Contribution of Langerhans Cell-Derived IL-18 to Contact Hypersensitivity
J. Immunol., April 1, 2002; 168(7): 3303 - 3308.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Jordan, R.-F. Guo, E. C. Yun, V. Sarma, R. L. Warner, L. D. Crouch, G. Senaldi, T. R. Ulich, and P. A. Ward
Role of IL-18 in Acute Lung Inflammation
J. Immunol., December 15, 2001; 167(12): 7060 - 7068.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
B. Anlar, F. Soylemezoglu, S. Aysun, G. Kose, D. Belen, and K. Yalaz
Tissue Inflammatory Response in Subacute Sclerosing Panencephalitis (SSPE)
J Child Neurol, December 1, 2001; 16(12): 895 - 900.
[Abstract] [PDF]


Home page
FASEB J.Home page
S.-H. IM, D. BARCHAN, P. K. MAITI, L. RAVEH, M. C. SOUROUJON, and S. FUCHS
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18
FASEB J, October 1, 2001; 15(12): 2140 - 2148.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Ogura, H. Ueda, K. Hosohara, R. Tsuji, Y. Nagata, S.-i. Kashiwamura, and H. Okamura
Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice
Blood, October 1, 2001; 98(7): 2101 - 2107.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Neighbors, X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra
A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria monocytogenes That Extends Beyond Its Effects on Interferon {gamma} Production
J. Exp. Med., August 6, 2001; 194(3): 343 - 354.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Nicoletti, R. Di Marco, K. Mangano, F. Patti, E. Reggio, A. Nicoletti, K. Bendtzen, and A. Reggio
Increased serum levels of interleukin-18 in patients with multiple sclerosis
Neurology, July 24, 2001; 57(2): 342 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Neumann, E. Del Giudice, A. Ciaramella, D. Boraschi, and P. Bossu
Lymphocytes from Autoimmune MRL lpr/lpr Mice Are Hyperresponsive to IL-18 and Overexpress the IL-18 Receptor Accessory Chain
J. Immunol., March 15, 2001; 166(6): 3757 - 3762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Debets, J. C. Timans, T. Churakowa, S. Zurawski, R. de Waal Malefyt, K. W. Moore, J. S. Abrams, A. O'Garra, J. F. Bazan, and R. A. Kastelein
IL-18 Receptors, Their Role in Ligand Binding and Function: Anti-IL-1RAcPL Antibody, a Potent Antagonist of IL-18
J. Immunol., November 1, 2000; 165(9): 4950 - 4956.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F.-D. Shi, K. Takeda, S. Akira, N. Sarvetnick, and H.-G. Ljunggren
IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-{gamma} by NK Cells
J. Immunol., September 15, 2000; 165(6): 3099 - 3104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. I. Karachunski, N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine
Absence of IFN-{gamma} or IL-12 Has Different Effects on Experimental Myasthenia Gravis in C57BL/6 Mice
J. Immunol., May 15, 2000; 164(10): 5236 - 5244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nakamura, T. Otani, Y. Ijiri, R. Motoda, M. Kurimoto, and K. Orita
IFN-{gamma}-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12
J. Immunol., March 15, 2000; 164(6): 3330 - 3336.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
I. A. Schrijver, M.-J. Melief, M. van Meurs, A. R. Companjen, and J. D. Laman
Pararosaniline Fixation for Detection of Co-stimulatory Molecules, Cytokines, and Specific Antibody
J. Histochem. Cytochem., January 1, 2000; 48(1): 95 - 104.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Siegmund, H.-A. Lehr, G. Fantuzzi, and C. A. Dinarello
IL-1beta -converting enzyme (caspase-1) in intestinal inflammation
PNAS, November 6, 2001; 98(23): 13249 - 13254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.